FDA Inspection
CTI Biopharma CorpCTI Biopharma Corp – FDA Inspection, Nov 18, 2009
Record Details
This FDA Inspection record concerns CTI Biopharma Corp, with an inspection on November 18, 2009, issued by the Center for Drug Evaluation and Research, covering drugs.
- Company
- CTI Biopharma Corp
- Inspection Date
- November 18, 2009
- Product Type
- Drugs
View Company Profile
ID · 0bac42bb-b407-4497-9021-80c55accdf54
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 628277
- FDA center
- Human Drugs
- Project area
- Bioresearch Monitoring
FDA Citations
1- 21 CFR 312.56(b)Notification of FDA of termination of investigator
Full citation text and observation details available on the Dashboard.
Other FDA inspections of CTI Biopharma Corp
1| Date | Classification | Office | Project area |
|---|---|---|---|
| May 25, 2021 | NAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
Other documents for CTI Biopharma Corp
- FDA Inspection 1143134 - 2021-05-25
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.